Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service medicare beneficiaries with schizophrenia in the United States.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2189859
Abstract: BACKGROUND No research to date has examined antipsychotic (AP) use, healthcare resource use (HRU), costs, and quality of care among those with schizophrenia in the Medicare program despite it serving as the primary payer for… read more here.
Keywords: medicare; costs quality; beneficiaries schizophrenia; medicare beneficiaries ... See more keywords